Enjoy complimentary customisation on priority with our Enterprise License!
The molecular biology enzymes, kits, and reagents market share is expected to increase by USD 13.09 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 14.61%.
This molecular biology enzymes, kits, and reagents market research report extensively covers molecular biology enzymes, kits, and reagents market segmentations by end-user (biotechnology and pharmaceutical companies, hospitals and diagnostic centers, and academic institutes and research organizations) and geography (North America, Europe, Asia, and ROW). The molecular biology enzymes, kits, and reagents market report also offers information on several market vendors, including Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc. , Takara Bio Inc., and Thermo Fisher Scientific Inc. among others.
Download the Free Report Sample to Unlock the Molecular Biology Enzymes, Kits, and Reagents Market Size for the Forecast Period and Other Important Statistics
The increased use of proteins and reagents in biotechnology and pharmaceutical companies is notably driving the molecular biology enzymes, kits, and reagents market growth, although factors such as privacy issues concerning data leakage of genetic information may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the molecular biology enzymes, kits, and reagents industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Molecular Biology Enzymes, Kits, and Reagents Market Driver
Biotechnology and pharmaceutical companies are increasingly opting for molecular biology enzymes, kits, and reagents for various applications. For instance, Vivantis Technologies Sdn. Bhd., a research-based biotechnology company headquartered in Malaysia, has experience in recombinant enzyme production and novel chemistry for the creation of consumables necessary for molecular biology research, which increases the demand for proteins and reagents. Similarly, pharmaceutical companies are using proteins, enzymes, and reagents for the treatment of rare genetic disorders and diseases such as Gaucher's disease. Thus, the increased use of proteins and reagents in biotechnology and pharmaceutical companies for applications such as drug discovery and development and in molecular biology research has propelled the growth of the global molecular biology enzymes, kits, and reagents market during the forecast period.
Key Molecular Biology Enzymes, Kits, and Reagents Market Trend
In recent years, end-users such as hospitals, diagnostic centers, academic institutes, and research organizations are increasingly opting for molecular biology kits that include enzymes and reagents for disease diagnosis. Molecular biology kits are highly used by end-users for the detection of molecular infectious diseases. These kits include primers, deoxyribonucleotide triphosphate (dNTPs), PCR buffers, and genomic DNA templates for monitoring PCR conditions and the comparison of the final amplified fragment. The advent of molecular technologies, coupled with the development of genomics, has significantly increased the use of molecular biology enzymes, kits, and reagents for the detection of pathogenic events at the genomic level. Such rising use of molecular biology kits for exploring disease-related genes and management of infectious diseases impacts the growth of the market positively.
Key Molecular Biology Enzymes, Kits, and Reagents Market Challenge
The technological advances that are enabling researchers to easily sequence and interpret genomic information required for research and clinical uses increased the risk of data privacy of an individual's genetic information. As genetic information is stored in cloud databases for easy access to doctors and insurance companies, there is an increased privacy concern related to its use globally. Moreover, the blood and tissue samples collected in medical settings during biopsies can serve as sources of samples for genetic analysis, which increases the chances of data leakage. Also, the use of genomic testing for routine procedures in clinical settings increases the threat to patient privacy, as patients are potentially vulnerable to the misuse of their genetic information. Such privacy concerns led to the decreased popularity of DNA testing for obtaining genetic information and the creation of databases using molecular biology enzymes, kits, and reagents.
This molecular biology enzymes, kits, and reagents market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
The growth in the global life sciences tools and services market will be driven by factors such as increasing life expectancy, expanding access to improved healthcare in emerging economies, and increasing prevalence of sedentary lifestyles. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the molecular biology enzymes, kits, and reagents market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the molecular biology enzymes, kits, and reagents market encompasses successful business strategies deployed by the key vendors. The molecular biology enzymes, kits, and reagents market is fragmented and the vendors are deploying growth strategies such as product launches and business expansions to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The molecular biology enzymes, kits, and reagents market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the molecular biology enzymes, kits, and reagents market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chains is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the life sciences tools and services market includes the following core components:
The report has further elucidated on other innovative approaches being followed by vendors to ensure a sustainable market presence.
***1. Executive Summary
***2. Market Landscape
**2.1 Market ecosystem
*Exhibit 01: Parent market
*Exhibit 02: Market Characteristics
**2.2 Value chain analysis
*Exhibit 03: Value chain analysis : Life sciences tools and services
*2.2.1 Research and development
*2.2.2 Inputs
*2.2.3 Production
*2.2.4 Distribution
*2.2.5 Marketing and sales
*2.2.6 Post-sales and services
*2.2.7 Industry innovations
***3. Market Sizing
**3.1 Market definition
*Exhibit 04: Offerings of vendors included in the market definition
**3.2 Market segment analysis
*Exhibit 05: Market segments
**3.3 Market size 2020
**3.4 Market outlook: Forecast for 2020 - 2025
*3.4.1 Estimating growth rates for emerging and high-growth markets
*3.4.2 Estimating growth rates for mature markets
*Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
*Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)
***4. Five Forces Analysis
**4.1 Five Forces Summary
*Exhibit 08: Five forces analysis 2020 & 2025
**4.2 Bargaining power of buyers
*Exhibit 09: Bargaining power of buyers
**4.3 Bargaining power of suppliers
*Exhibit 10: Bargaining power of suppliers
**4.4 Threat of new entrants
*Exhibit 11: Threat of new entrants
**4.5 Threat of substitutes
*Exhibit 12: Threat of substitutes
**4.6 Threat of rivalry
*Exhibit 13: Threat of rivalry
**4.7 Market condition
*Exhibit 14: Market condition - Five forces 2020
***5. Market Segmentation by End-user
**5.1 Market segments
*The segments covered in this chapter are:
*Exhibit 15: End-user - Market share 2020-2025 (%)
**5.2 Comparison by End-user
*Exhibit 16: Comparison by End-user
**5.3 Biotechnology and pharmaceutical companies - Market size and forecast 2020-2025
*Exhibit 17: Biotechnology and pharmaceutical companies - Market size and forecast 2020-2025 ($ million)
*Exhibit 18: Biotechnology and pharmaceutical companies - Year-over-year growth 2020-2025 (%)
**5.4 Hospitals and diagnostic centers - Market size and forecast 2020-2025
*Exhibit 19: Hospitals and diagnostic centers - Market size and forecast 2020-2025 ($ million)
*Exhibit 20: Hospitals and diagnostic centers - Year-over-year growth 2020-2025 (%)
**5.5 Academic institutes and research organizations - Market size and forecast 2020-2025
*Exhibit 21: Academic institutes and research organizations - Market size and forecast 2020-2025 ($ million)
*Exhibit 22: Academic institutes and research organizations - Year-over-year growth 2020-2025 (%)
**5.6 Market opportunity by End-user
*Exhibit 23: Market opportunity by End-user
***6. Customer landscape
*Exhibit 24: Customer landscape
***7. Geographic Landscape
**7.1 Geographic segmentation
*The regions covered in the report are:
*Exhibit 25: Market share by geography 2020-2025 (%)
**7.2 Geographic comparison
*Exhibit 26: Geographic comparison
**7.3 North America - Market size and forecast 2020-2025
*Exhibit 27: North America - Market size and forecast 2020-2025 ($ million)
*Exhibit 28: North America - Year-over-year growth 2020-2025 (%)
**7.4 Europe - Market size and forecast 2020-2025
*Exhibit 29: Europe - Market size and forecast 2020-2025 ($ million)
*Exhibit 30: Europe - Year-over-year growth 2020-2025 (%)
**7.5 APAC - Market size and forecast 2020-2025
*Exhibit 31: APAC - Market size and forecast 2020-2025 ($ million)
*Exhibit 32: APAC - Year-over-year growth 2020-2025 (%)
**7.6 ROW - Market size and forecast 2020-2025
*Exhibit 33: ROW - Market size and forecast 2020-2025 ($ million)
*Exhibit 34: ROW - Year-over-year growth 2020-2025 (%)
**7.7 Key leading countries
*Exhibit 35: Key leading countries
**7.8 Market opportunity by geography
*Exhibit 36: Market opportunity by geography ($ million)
***8. Drivers, Challenges, and Trends
**8.1 Market drivers
*8.1.1 Increased use of proteins and reagents in biotechnology and pharmaceutical companies
*8.1.2 Rising incidence of infectious diseases and genetic disorders
*8.1.3 Rising number of genome projects
**8.2 Market challenges
*8.2.1 Privacy issues concerning data leakage of genetic information
*8.2.2 High costs and lack of reimbursement policies for genetic testing
*8.2.3 Lack of skilled workforce to handle patient data and perform molecular diagnostic techniques
*Exhibit 37: Impact of drivers and challenges
**8.3 Market trends
*8.3.1 Rising use of molecular biology kits for disease diagnosis
*8.3.2 Increasing number of applications of molecular biology enzymes, kits, and reagents
*8.3.3 Technological advances in the life sciences industry
***9. Vendor Landscape
**9.1 Vendor landscape
*Exhibit 38: Vendor landscape
**9.2 Landscape disruption
*Exhibit 39: Landscape disruption
*Exhibit 40: Industry risks
**9.3 Competitive Landscape
***10. Vendor Analysis
**10.1 Vendors covered
*Exhibit 41: Vendors covered
**10.2 Market positioning of vendors
*Exhibit 42: Market positioning of vendors
**10.3 Agilent Technologies Inc.
*Exhibit 43: Agilent Technologies Inc. - Overview
*Exhibit 44: Agilent Technologies Inc. - Business segments
*Exhibit 45: Agilent Technologies Inc. - Key news
*Exhibit 46: Agilent Technologies Inc. - Key offerings
*Exhibit 47: Agilent Technologies Inc. - Segment focus
*10.4 F. Hoffmann-La Roche Ltd.
**Exhibit 48: F. Hoffmann-La Roche Ltd. - Overview
**Exhibit 49: F. Hoffmann-La Roche Ltd. - Business segments
**Exhibit 50: F. Hoffmann-La Roche Ltd. - Key news
**Exhibit 51: F. Hoffmann-La Roche Ltd. - Key offerings
**Exhibit 52: F. Hoffmann-La Roche Ltd. - Segment focus
**10.5 Illumina Inc.
*Exhibit 53: Illumina Inc. - Overview
*Exhibit 54: Illumina Inc. - Product and service
*Exhibit 55: Illumina Inc.- Key news
*Exhibit 56: Illumina Inc. - Key offerings
**10.6 Merck KGaA
*Exhibit 57: Merck KGaA - Overview
*Exhibit 58: Merck KGaA - Business segments
*Exhibit 59: Merck KGaA - Key news
*Exhibit 60: Merck KGaA - Key offerings
*Exhibit 61: Merck KGaA - Segment focus
**10.7 New England Biolabs Inc.
*Exhibit 62: New England Biolabs Inc. - Overview
*Exhibit 63: New England Biolabs Inc. - Product and service
*Exhibit 64: New England Biolabs Inc.- Key news
*Exhibit 65: New England Biolabs Inc. - Key offerings
**10.8 Promega Corp.
*Exhibit 66: Promega Corp. - Overview
*Exhibit 67: Promega Corp. - Product and service
*Exhibit 68: Promega Corp..- Key news
*Exhibit 69: Promega Corp. - Key offerings
**10.9 QIAGEN NV
*Exhibit 70: QIAGEN NV - Overview
*Exhibit 71: QIAGEN NV - Business segments
*Exhibit 72: QIAGEN NV- Key news
*Exhibit 73: QIAGEN NV - Key offerings
*Exhibit 74: QIAGEN NV - Segment focus
**10.10 Rockland Immunochemicals Inc.
*Exhibit 75: Rockland Immunochemicals Inc. - Overview
*Exhibit 76: Rockland Immunochemicals Inc. - Product and service
*Exhibit 77: Rockland Immunochemicals Inc. - Key news
*Exhibit 78: Rockland Immunochemicals Inc. - Key offerings
**10.11 Takara Bio Inc.
*Exhibit 79: Takara Bio Inc. - Overview
*Exhibit 80: Takara Bio Inc. - Business segments
*Exhibit 81: Takara Bio Inc. - Key news
*Exhibit 82: Takara Bio Inc. - Key offerings
*Exhibit 83: Takara Bio Inc. - Segment focus
**10.12 Thermo Fisher Scientific Inc.
*Exhibit 84: Thermo Fisher Scientific Inc. - Overview
*Exhibit 85: Thermo Fisher Scientific Inc. - Business segments
*Exhibit 86: Thermo Fisher Scientific Inc. - Key news
*Exhibit 87: Thermo Fisher Scientific Inc. - Key offerings
*Exhibit 88: Thermo Fisher Scientific Inc. - Segment focus
***11. Appendix
**11.1 Scope of the report
*11.1.1 ????Market definition
*11.1.2 Objective
*11.1.3 Notes and caveats
**11.2 Currency conversion rates for US$
*Exhibit 89: Currency conversion rates for US$
**11.3 Research Methodology
*Exhibit 90: Research Methodology
*Exhibit 91: Validation techniques employed for market sizing
*Exhibit 92: Information sources
**11.4 List of abbreviations
*Exhibit 93: List of abbreviations
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.